Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece.
Saved in:
| Title: | Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece. |
|---|---|
| Authors: | Dardiotis, Efthymios1 (AUTHOR), Perpati, Georgia2 (AUTHOR), Borsos, Mariann3 (AUTHOR), Nikolaidis, Ioannis4 (AUTHOR), Tzanetakos, Dimitrios5 (AUTHOR), Deretzi, Georgia6 (AUTHOR), Koutlas, Evangelos6 (AUTHOR), Kilidireas, Constantinos5 (AUTHOR), Mitsikostas, Dimos Dimitrios5 (AUTHOR), Hadjigeorgiou, Georgios1 (AUTHOR), Grigoriadis, Nikolaos4 (AUTHOR) ngrigoriadis@auth.gr, The AURELIO investigators (AUTHOR), Papagiannopoulos, Sotirios (AUTHOR), Orologas, Anastasios (AUTHOR), Aggelidakis, Panagiotis (AUTHOR), Antonios, Antonios (AUTHOR), Fakas, Nicolaos (AUTHOR), Papadimitriou, Alexandros (AUTHOR), Iliopoulos, Ioannis (AUTHOR), Kostadima, Vasiliki (AUTHOR) |
| Source: | Neurology & Therapy. Sep2022, Vol. 11 Issue 3, p1375-1390. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
